Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4. by Naoya Itoh (6029276)

Subjects:

Significantly changed USSs in the sf3b1 mutants. by Bei Zhang (428038)

“+” (red) is indicated that the impact of senior executives’ home bias on employee social responsibility (ESR) is significantly positive. by Tingting Zhang (264633)

Subjects:

Discussions of costs in clinical practice. by Anupriya Agarwal (262443)

Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

“…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …”

Total unexpected costs by medical school year of training. by Madeleine Ball (6405131)

Impact of unexpected costs during medical school by race. by Madeleine Ball (6405131)

Significant differences between Th17-cell levels of dogs suffering from IVDH at all three sampling time points and in comparison with the healthy control group. by Annika Kämpe (11507012)

Theoretical framework of the lean cost module. by Yichen Yin (6649409)

“…The application of the SLSM mode to a private machinery manufacturing company in Wenzhou resulted in the effective shouldering of safety responsibilities by the company, a year-on-year decrease in accident rates, and a significant increase in production efficiency, thereby providing corporate managers with guidance and suggestions for making improvements.…”

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

Multivariate linear regression analysis of the relationship between the rate of alert detection by an attending physician and direct cost as well as total cost. by Hai-bo Ai (20790405)

Subjects:

Shows 48/86 genes have differential expression consistent with the direction of decrease in cell movement. by Afrooz Jahedi (14636554)

Cost-effectiveness acceptability plane: Cost-utility analysis with life-time horizon. by Emily Holmes (418302)

Subjects:

Costs savings breakdown per tray. by Jay Toor (14309485)

Subjects:

Mean± SD of hospitalization cost of lung cancer by study years and discounting. by Habib Jalilian (11328174)

Subjects:

Mean ±SD of Hospitalization cost of lung cancer before and after the HSEP. by Habib Jalilian (11328174)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

Treatment costs and premature mortality costs in 2020 and 2021 (in constant 2020 USD). by Adeyemi Okunogbe (9101644)

Subjects:

OOP cost across age of the study sample. by Abdur Razzaque Sarker (7542854)